[Methylphenidate-induced psychiatric disorders].
Ozaki
Shigeru
S
Division of Drug Dependence Research, Section of Psycho-Social Factors Research, National Institute of Mental Health, NCNP.
D000328:Adult; D019969:Amphetamine-Related Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D014150:Antipsychotic Agents / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D011307:Drug Prescriptions; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D038801:International Classification of Diseases; D008297:Male; D008774:Methylphenidate / Q000009:adverse effects*; D008875:Middle Aged
D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D006220:Haloperidol